Hyaluronic Acid (Single Injection, Three Injection, Five Injection) Market for Osteoarthritis, Adhesive Prevention, Drug Delivery, Dermal Fillers Applications - Global Industry Perspective, Comprehensive Analysis, Size, Share, Growth, Segment, Trends and Forecast, 2014-2020

February 2016 | 110 pages | ID: H6F2C2FA98CEN
Zion Market Research

Abstracts

The report covers forecast and analysis for the hyaluronic acid market on a global and regional level. The study provides historic data of 2014 along with a forecast from 2015 to 2020 based revenue (USD Million). The study includes drivers and restraints for the hyaluronic acid market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the hyaluronic acid market on a global level.

In order to give the users of this report a comprehensive view on the hyaluronic acid market we have included a detailed competitive scenario and product portfolio of key vendors. To understand the competitive landscape in the market, an analysis of Porters five forces model for the hyaluronic acid market has also been included. The study encompasses a market attractiveness analysis, wherein product segments and application segments are benchmarked based on their market size, growth rate and general attractiveness.

The study provides a decisive view on the hyaluronic acid market by segmenting the market based on products, applications and regions. All the segments have been analyzed based on present and future trends and the market is estimated from 2014 to 2020. Based on products the market is segmented into single injection, three injections, and five injections. Key application market covered under this study includes osteoarthritis, adhesive prevention, drug delivery, dermal fillers. The regional segmentation includes the current and forecast demand for North America, Europe, Asia Pacific, Latin America and Middle East Africa with its further bifurcation into major countries including U.S. Germany, France, UK, China, Japan, India and Brazil. This segmentation includes demand for hyaluronic acid based on individual applications in all the regions and countries.

The report also includes detailed profiles of end players such as Alcon, Inc., Allergan, Inc., Anika Therapeutics, Inc., F. Hoffmann-La Roche Ltd., Ferring Pharmaceuticals, Inc., Fidia Farmaceutici SpA, GALDERMA S.A., Hyaltech Ltd., LifeCore Biomedical LLC, Meiji Seika Pharma Co., Ltd., Merz Aesthetics, Inc., Sanofi, Salix Pharmaceuticals, Inc., Seikagaku Corporation, Shanghai Jingfeng Pharmaceutical Co., Ltd., Smith Nephew plc, TRB CHEMEDICA INTERNATIONAL SA, Zimmer Holdings, Inc. The detailed description of players includes parameters such as company overview, financial overview, business strategies and recent developments of the company. This report segments the global hyaluronic acid market as follows: Global Hyaluronic Acid Market: Product Segment Analysis

• Single-injection
• Three-injection
• Five-injection

Global Hyaluronic Acid Market: Application Segment Analysis

• Osteoarthritis
• Adhesive Prevention
• Drug Delivery
• Dermal Fillers

Global Hyaluronic Acid Market: Regional Segment Analysis

• North America
• U.S.
• Europe
• UK
• France
• Germany
• Asia Pacific
• China
• Japan
• India
• Latin America
• Brazil
• Middle East Africa

Contents

CHAPTER 1. INTRODUCTION

1.1. Report description and scope
1.2. Research scope
1.3. Research methodology
  1.3.1. Market research process
  1.3.2. Market research methodology

CHAPTER 2. EXECUTIVE SUMMARY

2.1. Global hyaluronic acid market, 2014 - 2020 (USD Million)
2.2. Global hyaluronic acid market : Snapshot

CHAPTER 3. HYALURONIC ACID MARKET DYNAMICS

3.1. Introduction
3.2. Market drivers
  3.2.1. Global hyaluronic acid market drivers: Impact analysis
  3.2.2. Growing medical and cosmetic applications
  3.2.3. Physical properties of hyaluronic acid products
3.3. Market restraints
  3.3.1. Global hyaluronic acid market restraints: Impact analysis
  3.3.2. Allergic reactions
  3.3.3. Cost effective treatments along with several regulations concerns
3.4. Opportunities
  3.4.1. Research and development
  3.4.2. Beauty products with hyaluronic acid
3.5. Porters five forces analysis
  3.5.1. Bargaining power of suppliers
  3.5.2. Bargaining power of buyers
  3.5.3. Threat from new entrants
  3.5.4. Threat from new substitutes
  3.5.5. Degree of competition
3.6. Market attractiveness analysis
  3.6.1. Market attractiveness analysis, by products segment
  3.6.2. Market attractiveness analysis, by application segment
  3.6.3. Market attractiveness analysis, by regional segment

CHAPTER 4. GLOBAL HYALURONIC ACID MARKET COMPETITIVE LANDSCAPE

4.1. Company market share, 2014
4.2. Price trend analysis

CHAPTER 5. GLOBAL HYALURONIC ACID MARKET PRODUCT SEGMENT ANALYSIS

5.1. Global hyaluronic acid market: Product overview
  5.1.1. Global hyaluronic acid market revenue share, by product, 2014 and 2020
5.2. Single Injection
  5.2.1. Global single injection market , 2014 2020 (USD Million)
5.3. Three Injection
  5.3.1. Global three injection market , 2014 2020 (USD Million)
5.4. Five Injection
  5.4.1. Global five injection market , 2014 2020 (USD Million)

CHAPTER 6. GLOBAL HYALURONIC ACID MARKET APPLICATION SEGMENT ANALYSIS

6.1. Global hyaluronic acid market: Application overview
  6.1.1. Global hyaluronic acid market revenue share, by application, 2014 and 2020
6.2. Osteoarthritis
  6.2.1. Global hyaluronic acid market for osteoarthritis, 2014 - 2020(USD Million)
6.3. Adhesive Prevention
  6.3.1. Global hyaluronic acid market for adhesive prevention, 2014 - 2020(USD Million)
6.4. Drug Delivery
  6.4.1. Global hyaluronic acid market for drug delivery, 2014 - 2020(USD Million)
6.5. Dermal Fillers
  6.5.1. Global hyaluronic acid market for dermal filters, 2014 - 2020(USD Million)

CHAPTER 7. GLOBAL HYALURONIC ACID MARKET REGIONAL SEGMENT ANALYSIS

7.1. Global hyaluronic acid market: Regional overview
  7.1.1. Global hyaluronic acid market revenue share, by region, 2014 and 2020
7.2. North America
  7.2.1. North America hyaluronic acid market revenue, by product, 2014 2020 (USD Million)
  7.2.2. North America hyaluronic acid market revenue, by application, 2014 2020 (USD Million)
  7.2.3. U.S.
    7.2.3.1. U.S. hyaluronic acid market revenue, by product, 2014 2020 (USD Million)
    7.2.3.2. U.S. hyaluronic acid market revenue, by application, 2014 2020 (USD Million)
7.3. Europe
  7.3.1. Europe hyaluronic acid market revenue, by product, 2014 2020 (USD Million)
  7.3.2. Europe hyaluronic acid market revenue, by application, 2014 2020 (USD Million)
  7.3.3. Germany
    7.3.3.1. Germany hyaluronic acid market revenue, by product, 2014 2020, (USD Million)
    7.3.3.2. Germany hyaluronic acid market revenue, by application, 2014 2020, (USD Million)
  7.3.4. France
    7.3.4.1. France hyaluronic acid market revenue, by product, 2014 2020, (USD Million)
    7.3.4.2. France hyaluronic acid market revenue, by application, 2014 2020, (USD Million)
  7.3.5. UK
    7.3.5.1. UK hyaluronic acid market revenue, by product, 2014 2020 (USD Million)
    7.3.5.2. UK hyaluronic acid market revenue, by application, 2014 2020 (USD Million)
7.4. Asia Pacific
  7.4.1. Asia Pacific hyaluronic acid market revenue, by product, 2014 2020, (USD Million)
  7.4.2. Asia Pacific hyaluronic acid market revenue, by application, 2014 2020, (USD Million)
  7.4.3. China
    7.4.3.1. China hyaluronic acid market revenue, by product, 2014 2020 (USD Million)
    7.4.3.2. China hyaluronic acid market revenue, by application, 2014 2020 (USD Million)
  7.4.4. Japan
    7.4.4.1. Japan hyaluronic acid market revenue, by product, 2014 2020 (USD Million)
    7.4.4.2. Japan hyaluronic acid market revenue, by application, 2014 2020 (USD Million)
  7.4.5. India
    7.4.5.1. India hyaluronic acid market revenue, by product, 2014 2020 (USD Million)
    7.4.5.2. India hyaluronic acid market revenue, by application, 2014 2020 (USD Million)
7.5. Latin America
  7.5.1. Latin America hyaluronic acid market revenue, by product, 2014 2020 (USD Million)
  7.5.2. Latin America hyaluronic acid market revenue, by application, 2014 2020 (USD Million)
  7.5.3. Brazil
    7.5.3.1. Brazil hyaluronic acid market revenue, by product, 2014 2020 (USD Million)
    7.5.3.2. Brazil hyaluronic acid market revenue, by application, 2014 2020 (USD Million)
7.6. Middle East Africa
  7.6.1. Middle East Africa hyaluronic acid market revenue, by product, 2014 2020 (USD Million)
  7.6.2. Middle East Africa hyaluronic acid market revenue, by application, 2014 2020 (USD Million)

CHAPTER 8. COMPANY PROFILE

8.1. Alcon, Inc.
  8.1.1. Overview
  8.1.2. Financials
  8.1.3. Product portfolio
  8.1.4. Business strategy
  8.1.5. Recent developments
8.2. Allergan, Inc.
  8.2.1. Overview
  8.2.2. Financials
  8.2.3. Product portfolio
  8.2.4. Business strategy
  8.2.5. Recent developments
8.3. Anika Therapeutics, Inc.
  8.3.1. Overview
  8.3.2. Financials
  8.3.3. Product portfolio
  8.3.4. Business strategy
  8.3.5. Recent developments
8.4. F. Hoffmann-La Roche Ltd.
  8.4.1. Overview
  8.4.2. Financials
  8.4.3. Product portfolio
  8.4.4. Business strategy
  8.4.5. Recent developments
8.5. Ferring Pharmaceuticals, Inc.
  8.5.1. Overview
  8.5.2. Financials
  8.5.3. Product portfolio
  8.5.4. Business strategy
  8.5.5. Recent developments
8.6. Fidia Farmaceutici SpA
  8.6.1. Overview
  8.6.2. Financials
  8.6.3. Product portfolio
  8.6.4. Business strategy
  8.6.5. Recent developments
8.7. GALDERMA S.A.
  8.7.1. Overview
  8.7.2. Financials
  8.7.3. Product portfolio
  8.7.4. Business strategy
  8.7.5. Recent developments
8.8. Hyaltech Ltd.
  8.8.1. Overview
  8.8.2. Financials
  8.8.3. Product portfolio
  8.8.4. Business strategy
  8.8.5. Recent developments
8.9. LifeCore Biomedical LLC
  8.9.1. Overview
  8.9.2. Financials
  8.9.3. Product portfolio
  8.9.4. Business strategy
  8.9.5. Recent developments
8.10. Meiji Seika Pharma Co.
  8.10.1. Overview
  8.10.2. Financials
  8.10.3. Product portfolio
  8.10.4. Business strategy
  8.10.5. Recent developments
8.11. Ltd., Merz Aesthetics, Inc.
  8.11.1. Overview
  8.11.2. Financials
  8.11.3. Product portfolio
  8.11.4. Business strategy
  8.11.5. Recent developments
8.12. Sanofi
  8.12.1. Overview
  8.12.2. Financials
  8.12.3. Product portfolio
  8.12.4. Business strategy
  8.12.5. Recent developments
8.13. Salix Pharmaceuticals, Inc.
  8.13.1. Overview
  8.13.2. Financials
  8.13.3. Product portfolio
  8.13.4. Business strategy
  8.13.5. Recent developments
8.14. Seikagaku Corporation
  8.14.1. Overview
  8.14.2. Financials
  8.14.3. Product portfolio
  8.14.4. Business strategy
  8.14.5. Recent developments
8.15. Shanghai Jingfeng Pharmaceutical Co. Ltd.
  8.15.1. Overview
  8.15.2. Financials
  8.15.3. Product portfolio
  8.15.4. Business strategy
  8.15.5. Recent developments
8.16. Smith Nephew plc
  8.16.1. Overview
  8.16.2. Financials
  8.16.3. Product portfolio
  8.16.4. Business strategy
  8.16.5. Recent developments
8.17. TRB CHEMEDICA INTERNATIONAL SA
  8.17.1. Overview
  8.17.2. Financials
  8.17.3. Product portfolio
  8.17.4. Business strategy
  8.17.5. Recent developments
8.18. Zimmer Holdings, Inc.
  8.18.1. Overview
  8.18.2. Financials
  8.18.3. Product portfolio
  8.18.4. Business strategy
  8.18.5. Recent developments